UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics

Molecular medicine (Cambridge, Mass.), 2018-09, Vol.24 (1), p.50-50, Article 50

2018

Volltextzugriff (PDF)

Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits

Cancer control, 2021, Vol.28, p.10732748211051924-10732748211051924

2021

Volltextzugriff (PDF)

Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients

Cancer control, 2021, Vol.28, p.10732748211056691-10732748211056691

2021

Volltextzugriff (PDF)

One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population

Frontiers in oncology, 2022-11, Vol.12, p.995408-995408

2022

Volltextzugriff (PDF)

Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review

Future science OA, 2019-06, Vol.5 (5), p.FSO378-FSO378

2019

Volltextzugriff (PDF)

Lorlatinib induced proteinuria: A case report

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.1037-1039

2021

Volltextzugriff (PDF)

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab

Case reports in dermatological medicine, 2019, Vol.2019 (2019), p.1-5

2019

Volltextzugriff (PDF)

A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study

Journal of oncology pharmacy practice, 2022-07, Vol.28 (5), p.1140-1151

2022

Volltextzugriff (PDF)

The State of the Art in Non–Small Cell Lung Cancer Immunotherapy

Seminars in thoracic and cardiovascular surgery, 2014, Vol.26 (1), p.26-35

Seetharamu, Nagashree, MD

2014

Volltextzugriff (PDF)

1430 Development of ICTIS: a novel scoring system for the inclusivity of advanced non-small-cell lung cancer immunotherapy clinical trials

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1593-A1593

2023

Volltextzugriff (PDF)

Mucosal Melanomas: A Case‐Based Review of the Literature

The oncologist (Dayton, Ohio), 2010-07, Vol.15 (7), p.772-781

2010

Volltextzugriff (PDF)

Hyperpigmentation due to imatinib: A rare case of cutaneous involvement

Journal of oncology pharmacy practice, 2020-09, Vol.26 (6), p.1511-1515

2020

Volltextzugriff (PDF)

Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer

Cancer control, 2022-01, Vol.29, p.10732748221077959-10732748221077959

2022

Volltextzugriff (PDF)

1429 Application of ICTIS to currently recruiting clinical trials: a novel scoring system to assess the inclusivity of advanced non-small-cell lung cancer immunotherapy trials

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1592-A1592

2023

Volltextzugriff (PDF)

Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon’s two-stage trial

BMJ open, 2023-04, Vol.13 (4), p.e064809-e064809

2023

Volltextzugriff (PDF)

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer

SAGE Open Medicine, 2021, Vol.9, p.205031212110177-20503121211017757

2021

Volltextzugriff (PDF)

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies

Clinical pathology (Thousand Oaks, Ventura County, Calif.), 2020, Vol.13, p.2632010X20921873-2632010X20921873

2020

Volltextzugriff (PDF)

New PD-L1 inhibitors in non-small cell lung cancer - impact of atezolizumab

Lung cancer (Auckland), 2017-01, Vol.8, p.67-78

2017

Volltextzugriff (PDF)

676 Pepinemab, a semaphorin 4D inhibitor, in combination with pembrolizumab induced formation of organized lymphoid aggregates in phase 1b/2 study for first-line treatment of R/M HNSCC (KEYNOTE-B84)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A767-A767

2023

Volltextzugriff (PDF)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer

Future science OA, 2020-10, Vol.6 (9), p.FSO606-FSO606

2020

Volltextzugriff (PDF)

PP01.01 High-risk histopathological correlates of stage I non-small cell lung cancer (NSCLC) outcomes

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e10-e10

2024

Volltextzugriff (PDF)

Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin, cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18019-e18019

2022

Volltextzugriff (PDF)

Disparities in lung cancer screening rates among the Hispanic/LatinX population

Lung cancer management, 2021-09, Vol.10 (3)

2021

Volltextzugriff (PDF)

Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas

Clinical otolaryngology, 2023-11, Vol.48 (6), p.915-919

2023

Volltextzugriff (PDF)

Facing a Pandemic While Pregnant

JAMA oncology, 2020-07, Vol.6 (7), p.985

2020

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(120)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics

Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits

Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients

One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population

Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review

Lorlatinib induced proteinuria: A case report

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab

A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study

The State of the Art in Non–Small Cell Lung Cancer Immunotherapy

1430 Development of ICTIS: a novel scoring system for the inclusivity of advanced non-small-cell lung cancer immunotherapy clinical trials

Mucosal Melanomas: A Case‐Based Review of the Literature

Hyperpigmentation due to imatinib: A rare case of cutaneous involvement

Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer

1429 Application of ICTIS to currently recruiting clinical trials: a novel scoring system to assess the inclusivity of advanced non-small-cell lung cancer immunotherapy trials

Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon’s two-stage trial

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies

New PD-L1 inhibitors in non-small cell lung cancer - impact of atezolizumab

676 Pepinemab, a semaphorin 4D inhibitor, in combination with pembrolizumab induced formation of organized lymphoid aggregates in phase 1b/2 study for first-line treatment of R/M HNSCC (KEYNOTE-B84)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer

PP01.01 High-risk histopathological correlates of stage I non-small cell lung cancer (NSCLC) outcomes

Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin, cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas

Disparities in lung cancer screening rates among the Hispanic/LatinX population

Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas

Facing a Pandemic While Pregnant

Suchergebnisse filtern